Exchange: NASDAQ·Updated 04:04 PM EDT
DXR logo

DXR Daxor Corp.

$11.56
$0.18
(1.55%)
Today
Closed $11.45
$0.11
(0.96%)
After Hours
Mkt Cap$35.55M
Vol26,884.00

About DXR

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
49

Neutral Sentiment

How do you feel about DXR?

Advertisement|Remove ads.